trending Market Intelligence /marketintelligence/en/news-insights/trending/4wFJKWTVaiTKcv0Rx3bvXg2 content esgSubNav
In This List

Exact Sciences plans underwritten public offering for common stock

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Exact Sciences plans underwritten public offering for common stock

Exact Sciences Corp. plans to sell 7 million common shares in an underwritten public offering.

The company has also granted underwriters an option to purchase up to 1,050,000 additional shares.

Exact Sciences plans to use the net proceeds to fund the expansion of Cologuard commercialization activities including to increase laboratory, manufacturing and customer service capacity, to fund product development efforts, and for general corporate and working capital purposes.

Jefferies LLC, BofA Merrill Lynch and Robert W. Baird & Co. Inc. are acting as underwriters for the offering.